| Financial Year |
March 31 2023 |
| Monetary Funds |
4,635,581,239.71 |
| Held-for-trading Financial Assets |
807,599,203.62 |
| Notes Receivable |
6,412,705.08 |
| Accounts Receivable |
1,204,799,285.06 |
| Advances to Suppliers |
145,468,457.37 |
| Other Receivables |
177,942,124.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
4,200,849.97 |
| Inventories |
1,863,165,249.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
419,481,621.99 |
| Other Current Assets |
1,459,521,196.09 |
| Total Current Assets |
10,814,872,218.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
156,952,446.45 |
| Long-term Equity Investment |
1,692,015,718.42 |
| Investment Properties |
51,966,995.08 |
| Fixed Assetes |
18,420,116,730.35 |
| Under-construction Projects |
1,928,653,271.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
567,552,380.37 |
| R&D expenses |
-- |
| Goodwill |
47,318,977.51 |
| Long-Term Deferred and Prepaid Expenses |
1,444,386,335.23 |
| Deferred Income Tax Assets |
368,015.97 |
| Other Non-Current Assets |
188,675,931.89 |
| Sub-Total of Non-Current Assets |
26,372,806,380.67 |
| Total Assets |
37,187,678,599.25 |
| Short-Term Loans |
356,847,500.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
287,660,414.11 |
| Accounts Payable |
2,488,845,074.87 |
| Accounts Received In Advance |
644,987,306.79 |
| Employee Compensation Payable |
962,548,199.81 |
| Taxes Payable |
25,729,713.77 |
| Interest Payable |
-- |
| Dividend Payable |
41,743,078.12 |
| Other payables |
785,962,547.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
55,558,248.15 |
| Other Current Liabilities |
1,913,716,539.19 |
| Sub-Total of Current Liabilities |
12,477,223,303.97 |
| Long-term Loans |
12,900,000.00 |
| Bonds Payable |
1,639,830,301.35 |
| Long-Term Accounts Payable |
22,513,202.57 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,637,300.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,774,934,327.10 |
| Total Liabilities |
14,252,157,631.07 |
| Paid-In Capital(Or Share Stock) |
5,000,717,686.00 |
| Capital Surplus |
13,140,914,014.08 |
| Surplus Reserve |
792,239,068.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,184,010,716.61 |
| Minority Stockholder's Interest |
822,487,006.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
22,113,033,961.41 |
| Owner's Equity（Stockholder's Equity） |
22,935,520,968.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
37,187,678,599.25 |
